UBM — Ulisse Biomed Spa Cashflow Statement
0.000.00%
Last trade - 00:00- €19.19m
- €18.02m
- €0.77m
- 25
- 20
- 36
- 14
Annual cashflow statement for Ulisse Biomed Spa, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.222 | -0.604 | -1.31 | -4.8 | -5.94 |
| Depreciation | |||||
| Non-Cash Items | -0.095 | -0.131 | -0.154 | -0.154 | 0 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.779 | 0.092 | 0.171 | 1.54 | -0.542 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.601 | -0.395 | -0.97 | -0.907 | -3.56 |
| Capital Expenditures | -0.108 | -0.956 | -0.228 | -0.099 | -0.036 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.001 | -0.002 | 0 | 0 | 0.006 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.109 | -0.958 | -0.228 | -0.099 | -0.03 |
| Financing Cash Flow Items | -0.021 | 0 | — | 0 | 2.26 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.023 | 6.3 | 0.002 | 0 | 2.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.733 | 4.95 | -1.2 | -1.01 | -1.28 |